pharma K-Bio Phase 3 Data: Clear Test Results Ahead K-Bio Phase 3 data is crucial for upcoming approvals and licensing deals in October. Discover… HarperOctober 1, 2026
pharma Price Controls: The Worst Impact on Tomorrow’s Medicine Price controls impact medicine by threatening future innovations and access to care. HarperSeptember 28, 2026
pharma Price of Survival: The Real Cost of Life-Saving Medications Price of survival reveals the harsh realities of medication costs and access in today's healthcare… HarperSeptember 24, 2026